Diabetes patients on Ozempic-like drugs more likely to develop gastroesophageal reflux disease
A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared with sodium-glucose cotransporter-2 (SGLT-2) inhibitors on the risk for gastroesophageal ...
Jul 15, 2025
0
0